Objective: To characterize the epidemiology of fluid overload and its association with mortality and duration of extracorporeal membrane oxygenation in children treated with extracorporeal membrane oxygenation. Design: Retrospective cohort study. Setting: Six tertiary children's hospital ICUs. Patients: Seven hundred fifty-six children younger than 18 years old treated with extracorporeal membrane oxygenation for greater than or equal to 24 hours from January 1, 2007, to December 31, 2011. Interventions: None. Measurements and Main Results: Overall survival to extracorporeal membrane oxygenation decannulation and hospital discharge was 74.9% (n = 566) and 57.7% (n = 436), respectively. Median fluid overload at extracorporeal membrane oxygenation initiation was 8.8% (interquartile range, 0.3-19.2), and it differed between hospital survivors and non survival, though not between extracorporeal membrane oxygenation survivors and non survivors. Median peak fluid overload on extracorporeal membrane oxygenation was 30.9% (interquartile range, 15.4-54.8). During extracorporeal membrane oxygenation, 84.8% had a peak fluid overload greater than or equal to 10%; 67.2% of patients had a peak fluid overload of greater than or equal to 20% and 29% of patients had a peak fluid overload of greater than or equal to 50%. The median peak fluid overload was lower in patients who survived on extracorporeal membrane oxygenation (27.2% vs 44.4%; p < 0.0001) and survived to hospital discharge (24.8% vs 43.3%; p < 0.0001). After adjusting for acute kidney injury, pH at extracorporeal membrane oxygenation initiation, nonrenal complications, extracorporeal membrane oxygenation mode, support type, center and patient age, the degree of fluid overload at extracorporeal membrane oxygenation initiation (p = 0.05), and the peak fluid overload on extracorporeal membrane oxygenation (p < 0.0001) predicted duration of extracorporeal membrane oxygenation in survivors. Multivariable analysis showed that peak fluid overload on extracorporeal membrane oxygenation (adjusted odds ratio,
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The Impact of Fluid Overload on Outcomes in Children Treated With Extracorporeal Membrane Oxygenation: A Multicenter Retrospective Cohort Study* 1.09; 95% CI, 1.04-1.15) predicted mortality on extracorporeal membrane oxygenation; fluid overload at extracorporeal membrane oxygenation initiation (adjusted odds ratio, 1.13; 95% CI, 1.05-1.22) and peak fluid overload (adjusted odds ratio, 1.18; 95% CI, 1.12-1.24) both predicted hospital morality. Conclusions: Fluid overload occurs commonly and is independently associated with adverse outcomes including increased mortality and increased duration of extracorporeal membrane oxygenation in a broad pediatric extracorporeal membrane oxygenation population. These results suggest that fluid overload is a potential target for intervention to improve outcomes in children on extracorporeal membrane oxygenation. (Pediatr Crit Care Med 2017; 18:1126-1135) Key Words: acute kidney injury; extracorporeal life support; extracorporeal membrane oxygenation; fluid overload; pediatric E xtracorporeal membrane oxygenation (ECMO) provides short-term life-saving therapy for pediatric patients with severe refractory cardiac and respiratory failure. Multiple studies have shown that the development of acute kidney injury (AKI) during ECMO is common in children and is associated with increased mortality (1) (2) (3) (4) (5) (6) (7) (8) .
Fluid overload (FO) is an important complication of AKI. In children treated with continuous renal replacement therapy (CRRT) (4, 9-13), children undergoing cardiac surgery (14) (15) (16) , and noncardiac surgery children admitted to the ICU (17, 18) , FO has been shown to be associated with adverse outcomes including ICU mortality, prolonged length of stay, and worse oxygenation. Children treated with ECMO are typically the most critically ill patients in the ICU and are likely to be at high risk for FO. Several single-center studies in children and neonates treated with ECMO have suggested an association between FO and adverse outcomes, including duration of ECMO and mortality (6, (19) (20) (21) . Given the consistent finding of the negative effect of FO on outcomes in patients treated with ECMO, FO may represent a clinically important target for interventions (such as CRRT) to improve patient outcomes. However, the extent to which the FO outcome associations are independent of or modified by the presence of AKI remains unclear. It is thus important to understand the temporal patterns of FO during ECMO at clinically relevant time points (e.g., ECMO initiation or discontinuation; when during ECMO treatment that FO is most severe) in order to understand the most critical potential FO intervention targets. Furthermore, there is a need for a large multicenter evaluation of the FO outcome association to enable generalizability of findings and control for other factors associated with outcomes.
The Kidney Interventions During Extracorporeal Membrane Oxygenation study group represents six centers in the United States and Canada established to study the epidemiology and impact of AKI, FO, and renal support therapy (RST) in children during ECMO (22) . With the overarching hypothesis that FO in children supported with ECMO is associated with higher morbidity and mortality, the aim of this study was to characterize FO in the broadest pediatric ECMO patient population reported to date. We sought to determine the independent associations of FO at ECMO initiation and peak FO during ECMO on survival and duration of ECMO. In addition, we report the temporal pattern of FO, including the timing of peak FO and change in FO during ECMO.
METHODS

Study Population
This study is a retrospective observational cohort study of pediatric patients on ECMO at six centers from January 1, 2007, to December 31, 2011. All patients younger than 18 years old at the time of ECMO initiation were included. Patients with multiple independent ECMO treatment episodes (ECMO runs) during a hospitalization were excluded from analysis. Patients for whom data from the retrospective chart review could not be matched with data from the Extracorporeal Life Support Organization (ELSO) international registry, and those with inadequate fluid balance data were also excluded. A detailed description of the inclusion/exclusion criteria and study population are outlined in Supplemental Figure 1 
Data Collection
Data sources for this study included the ELSO Registry (ELSO, Ann Arbor, MI), and data were obtained retrospectively from individuals' medical records. Data from the ELSO registry was merged with the retrospective database, using a four-point matching scheme (ELSO ID, date of birth, date of ECMO initiation, and date of ECMO discontinuation) as previously reported (1 (1) . Medical charts were reviewed for AKI and FO-specific variables including all serum creatinine (SCr) values, RST, detailed FO data before, during, and at ECMO discontinuation ( Table 1) .
All SCr values measured before and during ECMO were evaluated. AKI was defined using the SCr criteria of the Kidney Disease Improving Global Outcome (KDIGO) AKI definition with two variations. The stage 3 criterion of estimated glomerular filtration rate less than 35 mL/min/1.73 m 2 at any time was not applied, because a large proportion of patients were neonates and as has been previously demonstrated, this criterion cannot be applied equally across patient ages (23) . Urine output criteria were not used in this study because hourly urine output was not consistently available. Baseline SCr was defined as the lowest SCr in the 3 months prior to ECMO cannulation. (24) . In the case of difference in AKI status between the two authors, a third author (M.Z.) broke the tie.
Fluid Overload
Daily cumulative percent FO was determined using daily intake and output for the 28 days prior to ECMO cannulation and the first 21 days following cannulation (9) . Cumulative percent FO was calculated according to previously published definition:
Sum of Daily (Fluid in liters Fluid out in liters)
ICU Adm − i ission Weight in kilograms 100 × We also determined the cumulative FO at ECMO cannulation and at ECMO discontinuation. We calculated the change in FO between ECMO initiation and discontinuation as follows:
Change in FOon ECMO= DiscontinuationFO% Initiation FO% −
Outcome
The primary outcome was in-hospital mortality. ECMO mortality and duration of ECMO served as secondary outcomes. ECMO mortality was defined as death while on ECMO or within 24 hours of ECMO decannulation.
Statistical Methods
Descriptive statistics were presented for the entire cohort and by in-hospital mortality status and mortality at ECMO decannulation. Median and interquartile range (IQR) were reported for continuous variables, and Wilcoxon ranksum test was used to test differences between the mortality groups. Frequency counts and percentages were reported for categorical variables, and differences between the mortality groups were tested using chi-square/Fisher exact test. Six categories (< 10% to ≥ 50%) each were formed for %FO at ECMO initiation and %peak FO (highest cumulative FO during ECMO) to evaluate the relationship between increasing %FO and mortality. The two independent variables, %FO initiation and %peak FO, were examined as 10% change. Univariate and multivariable logistic regressions (adjusting for age, center, mode, support type, patient complications, AKI [yes/no], and pH) were used to examine the relations (odds ratios [ORs] and 95% CI) between %FO at ECMO initiation and %peak FO with ECMO mortality and hospital mortality. In these analyses, %FO was rescaled, so that each unit increase in the rescaled value represented an absolute 10% increase in FO.
The relationship between %FO and duration of ECMO was examined using linear regression. In these analyses, ECMO duration was log transformed because of positive skewness, and results were presented after back transforming the log estimates for better interpretability. Two-sided analyses were performed with p value of less than or equal to 0.05 considered to be statistically significant. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
Patient Characteristics
During the study period, 1,009 patients supported with ECMO were identified by study sites. After exclusions, 756 patients were included in this analysis (Supplemental Fig. 1 Table 3) . During ECMO, 84.8% developed a peak FO greater than or equal to 10%; 67.2% of patients developed a peak FO greater than or equal to 20% and 29% of patients developed a peak FO greater than or equal to 50% ( Table 2 ). The median peak FO on ECMO was 30.9% (IQR, 15.4-54.8) ( Table 3 ). The median day of peak FO attainment on ECMO was day 3 (IQR, 1-8). The median FO at ECMO discontinuation or death was 25.3% (IQR, 9.7-51.2), and median change in FO on ECMO was positive 13.6% (IQR, 1.8-32.4) ( Table 3 ). The characteristics of FO were examined separately in two distinct populations including those who received RST (n = 380) and the neonatal population (n = 450) and are also presented in Table 3 . Those who received RST differed significantly from those who did not in each of the FO characteristics examined including a higher degree of FO at ECMO initiation (p = 0.02), higher peak FO on ECMO (p < 0.0001), and later date of peak FO (p = 0.01). The neonatal population only differed significantly from pediatric patients by having a higher peak FO on ECMO (p = 0.0003) and a greater change in FO on ECMO (p = 0.004).
Association of FO and Mortality
Survival to ECMO decannulation and hospital discharge were 74.9% (n = 566) and 57.8% (n = 436), respectively. The associations of different measures of FO with mortality are shown in Table 3 . Peak FO, FO at ECMO discontinuation, and FO change during ECMO were all higher in patients who died on ECMO. FO at ECMO initiation was not associated with ECMO mortality. FO at ECMO initiation, peak FO, FO at ECMO discontinuation, and change in FO on ECMO were all significantly higher in patients who died during hospitalization (Table 3) . Figure 1 , A and B shows that in general, there was a graded increase in both ECMO and hospital mortality with increasing FO (by 10% intervals). There was a somewhat sharp increase in mortality at the 20% ECMO initiation FO severity stratum; the inflection point for increased mortality for peak FO during ECMO was at 30% peak FO (Fig. 1, A and B) .
When the degree of FO was examined as a dichotomous variable, a FO level of greater than 20% at ECMO initiation was associated with increased ECMO mortality (35.2% vs 22%; p = 0.0003) and increased hospital mortality (57.1% vs 37.6%; p= 0.0001). Similarly, a peak FO level of greater than 30% during ECMO was associated with increased ECMO mortality (34% vs 15.9%; p < 0.0001) and increased hospital mortality (56.4% vs 27.8%; p < 0.0001).
Univariate logistic regression analysis showed that each 10% rise in FO at ECMO initiation was associated with significantly higher hospital mortality risk (OR, 1.12; 95% CI, 1.04-1.19; Table 4 ), FO at ECMO initiation was associated with increased hospital mortality, but not with ECMO mortality. As shown in Table 4 , Peak FO during ECMO was associated with both ECMO mortality (each 10% rise in peak FO was associated with a 9% increased odds of ECMO mortality) and hospital mortality (each 10% rise in peak FO associated with a 17% increased odds of hospital mortality), independent of other variables.
Of note, in all multivariable models, the presence of AKI more than doubled the odds of both ECMO mortality and hospital mortality (Table 4) . Examining neonatal and pediatric populations separately, the multivariable results in each population were similar to those of the whole cohort (Supplemental Table  2 , Supplemental Digital Content 3, http://links.lww. com/PCC/A538).
In order to begin to evaluate the importance of fluid balance on ECMO, the same multivariable models were evaluated replacing the FO term with a dichotomous term evaluating those with a positive fluid balance on ECMO. In these multivariable analyses (controlled for presence of AKI, pH at ECMO initiation, nonrenal complications, ECMO mode, support type, center, and age), a positive fluid balance on ECMO was associated with increased ECMO mortality (adjusted OR [aOR], 2.94; 95% CI 1.66-5.22; p = 0.0002) and hospital mortality (aOR, 2.28; 95% CI, 1.44-3.63; p = 0.001).
An analysis evaluating the outcomes in the 79 patients who were excluded after ELSO matching showed that those who were excluded had significantly higher ECMO mortality (47.4% vs 25.1%; p < 0.0001) and hospital mortality (65.8% vs 42.3%; p < 0.0001).
Association Between FO and ECMO Duration
The median duration of ECMO was 147 hours (IQR, 84-262.5). The median duration of ECMO in survivors was 143.5 hours (IQR, 88-241). In order to evaluate the impact of FO on duration of ECMO, only ECMO survivors were included in the analysis (n = 566). In multivariable analysis ( Table 5) , both FO at ECMO initiation and peak FO were associated with longer ECMO duration (hr), independent of other factors. Specifically, each 10% rise in FO at ECMO initiation was associated with a 2% relative increase in the number of hours on ECMO (p = 0.05); each 10% rise in peak FO on ECMO was associated with a 6% relative increase in the number of hours on ECMO (p < 0.0001) ( Table 5 ). Examining neonatal and pediatric populations separately, the results in each population did not differ meaningfully from the whole cohort (Supplemental Table 3 
DISCUSSION
This study is the first comprehensive multicenter evaluation of the temporal and severity patterns of FO and FO association with patient outcomes in children treated with ECMO. Our study shows that severe FO commonly occurs in children on ECMO and that worse FO during ECMO is associated with mortality and ECMO duration, independent of other factors, including the presence of AKI.
In a variety of adult and pediatric patient populations, FO has been shown to be associated with adverse outcomes including prolonged mechanical ventilation, increased length of stay, and increased mortality. Swaniker et al (19) first demonstrated the importance of FO in 128 children treated with ECMO for respiratory failure. This group showed that 41% of patients had significant FO (> 10% above their dry weight) at ECMO initiation. The physiology of FO in children on ECMO was investigated using radiolabeled isotopes, showing an elevation in both the total body water and extracellular fluid (25) . In neonates treated with ECMO for pulmonary hypertension, the degree of FO and improvement were key determinants of ECMO duration (26) . In the 2 decades since these publications, there have been few publications describing the epidemiology of FO in children on ECMO. We found that almost half of ECMO-treated children have greater than or equal to 10% FO at ECMO initiation, strongly suggesting that future studies should evaluate factors leading to FO and interventions to reduce pre-ECMO FO. Peak FO on ECMO was very high in our cohort with almost all attaining peak FO greater than or equal to 10% and over half with peak FO greater than or equal to 30%. Considering that in non-ECMO children in the ICU greater than or equal to 10%, FO has been suggested as an intervention threshold (27) and considering that in non-ECMO children in the ICU greater than or equal to 20% FO has been repeatedly been shown to be associated with poor outcomes (11) , this level of FO in patients on ECMO is concerning and may benefit from intervention. Although no FO management guidelines exist for ECMO, the ELSO makes the following statement about fluid status in ECMO, "the goal of fluid management is to return the extracellular volume to normal (dry weight) and maintain it there" (ELSO, 2016). Future research should now evaluate potential interventions to reduce FO on ECMO (such as diuresis, early initiation of RST) to determine the extent to which FO improvement on ECMO is feasible and hopefully associated with better outcomes.
The independent contribution of FO to adverse outcomes has become clear across a variety of patient populations (3, 4, 9, 11-15, 17, 28-30) . The impact of FO on outcomes in children has been robustly demonstrated in children undergoing CRRT, where the degree of FO at CRRT initiation has been consistently shown to be associated with increased mortality (3, 4, 9, (11) (12) (13) . The impact of FO on outcomes has since demonstrated in a number of other critically ill populations including term neonates, children with sepsis, those undergoing cardiac surgery, and mechanically ventilated children (14, 15, 17, (28) (29) (30) . Most studies on FO in ECMO patients have been single center. Recently, Selewski et al (3) demonstrated an association between FO at CRRT initiation and increased mortality in 53 pediatric ECMO patients. To date, there has not been a systematic evaluation of the impact of FO on outcomes in a general pediatric ECMO population. We found that the peak FO during ECMO is a significant predictor of ECMO mortality and in-hospital mortality. Furthermore, the degree of peak FO is associated with significant increases in duration of ECMO. This is the first study to demonstrate the impact of FO at ECMO initiation and during ECMO on mortality in an inclusive pediatric ECMO patient population. Our data raise important questions about FO as a target for therapeutic intervention and provides a fundamental building block describing the epidemiology of FO.
Early in the history of ECMO, the potential impact of FO change during ECMO on outcomes in children was recognized. In 2000, Swaniker et al (19) showed that FO decreased from 9% to 4% from ECMO initiation to discontinuation (respectively) in ECMO survivors, versus an increase in FO from 25% to 35% in nonsurvivors. A recent adult study by Schmidt et al (21) echoed these findings, showing that survivors had a lower fluid balance on ECMO days 3-5. The current study shows that the change in FO is associated with mortality. Importantly, we found that over 75% of patients had a positive fluid balance while on ECMO, suggesting that FO and the ability to achieve a negative fluid balance are potentially important therapeutic targets. Furthermore, we have also shown on multivariable analysis that the ability to achieve a negative fluid balance on ECMO is associated with improved survival. This raises the possibility of using CRRT as a potential intervention in patients on ECMO, with FO as an indication for CRRT initiation (3, 4, 19, 26) . CRRT provides flexibility and control in fluid management and has been shown to enhance the ability to achieve dry weight and negative fluid balance during ECMO (31, 32) . Our current study shows that children who received RST had higher degrees of peak FO on ECMO and a later peak FO, which may be interpreted as a need for earlier intervention. Taken together with the epidemiology of FO and its independent association with adverse outcomes in this study, these results suggest that a trial using CRRT to manage fluid in children on ECMO may be warranted. The current study provides data from which a trial on fluid management during ECMO may be designed.
The biggest strengths of this study is the multicenter approach that captured ample sample size to explore the impact of confounders in the association with outcomes. Despite these strengths, we acknowledge several limitations. Efforts were made to adjust for severity of illness, but the dataset did not have the data points necessary to calculate recently published severity of illness scores. Another limitation was that we were unable to merge approximately 20% of our identified center patients who received ECMO with the ELSO data. Also patients who were excluded after matching had higher mortality than the study cohort potentially biasing our results to lower mortality. Another limitation is that data were not available describing which patients were postoperative cardiac surgery patients, which prevented their separate evaluation. This study also did not note the types of fluids (colloid vs crystalloid vs blood products) that patients received, which may potentially impact patient outcomes independent of fluid amount. The authors also acknowledge the limitations of solely using SCr (without urine output data) to calculate AKI, which is not only a delayed marker of AKI but may be confounded by the presence of FO. Although our study is multicenter, generalizability may be limited for centers performing very little ECMO or with general ICU practice patterns differing substantially from our study centers. Within our own cohort, outcomes differed across centers; however, due to the retrospective nature of this study, it was not possible to evaluate the effect of individual physician practice differences, which may also impact the FO outcome association. Further study is warranted to identify center-specific practices and characteristics that impact outcomes, with a goal of standardizing fluid management practice, developing guidelines, and evaluating impact of center-variability reduction of improving patient outcomes.
CONCLUSION
In this 5-year retrospective multicenter cohort study, we show that FO occurs commonly in children on ECMO. Furthermore, we demonstrate the association between FO and adverse outcomes including increased mortality and increased length of ECMO in a broad pediatric ECMO population. The results of this study suggest that FO is a potential target for intervention to improve outcomes in children on ECMO.
